Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics is a research paper published in Frontiers in Neuroscience (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: P50-NS108675
National Institute of Neurological Disorders and Stroke
Grant: R33-NS097643
NINDS NIH HHS
Grant: R33 NS097643
NINDS NIH HHS
Grant: R01 NS064934
NINDS NIH HHS
Grant: P50 NS108675
National Institutes of Health
Grant: 5R33NS097643-04
Efficacies and Pharmacodynamic Assays for LRRk2 Small-Molecule Inhibitors
National Institutes of Health
Grant: 5R01NS064934-11
Mechanisms of LRRK2 Mediated Neurotoxicity
National Institutes of Health
Grant: 5P50NS108675-02
Innate and Adaptive Immunity in Parkinson Disease
FWCI
1.43
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals